Status:
COMPLETED
Dexmedetomidine PKPD Modeling and the Influence of Auditory Stimulation on Dexmedetomidine Effect
Lead Sponsor:
University Medical Center Groningen
Conditions:
Anesthesia
Sedation
Eligibility:
All Genders
18-72 years
Phase:
NA
Brief Summary
Dexmedetomidine is an α2-adrenoceptor agonist that has only recently been registered for human use in Europe. It has sedative, analgesic and anxiolytic properties, but patients remain arousable. This ...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) Physical Status 1
- No medical history of significance
- No chronic use of medication, alcohol, drugs or tobacco (oral contraceptives excluded)
Exclusion
- Contraindications for use of dexmedetomidine
- Known intolerance to dexmedetomidine
- Body mass index (BMI) \<18 or \>30 kg/m2
- Volunteer refusal
- Pregnancy, or currently nursing
- Bilateral non-patent ulnar artery
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01879865
Start Date
June 1 2013
End Date
November 1 2013
Last Update
April 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen
Groningen, Netherlands, 9713EZ